Natural tyrosinase enzyme inhibitors: A path from melanin to melanoma and its reported pharmacological activities.

[1]  J. Chen,et al.  How cancer hijacks the body’s homeostasis through the neuroendocrine system , 2023, Trends in Neurosciences.

[2]  T. Sarna,et al.  Melanoma, Melanin, and Melanogenesis: The Yin and Yang Relationship , 2022, Frontiers in Oncology.

[3]  L. Hritcu,et al.  Insights on the Inhibitory Power of Flavonoids on Tyrosinase Activity: A Survey from 2016 to 2021 , 2021, Molecules.

[4]  M. Duca,et al.  Potent Tyrosinase Inhibitory Activity of Curcuminoid Analogues and Inhibition Kinetics Studies , 2021, Cosmetics.

[5]  N. Lall,et al.  The effect of Aspalathus linearis (Burm.f.) R.Dahlgren and its compounds on tyrosinase and melanogenesis , 2021, Scientific Reports.

[6]  Guangliang Bian,et al.  Recent advance in the discovery of tyrosinase inhibitors from natural sources via separation methods , 2021, Journal of enzyme inhibition and medicinal chemistry.

[7]  J. van Staden,et al.  Cosmeceutical efficiency by some plant extracts used traditionally for skin care in inhibiting tyrosinase activity in a human epidermal melanocyte (HEM) cell line , 2019, South African Journal of Botany.

[8]  N. Lall,et al.  Antityrosinase and anti-acne potential of plants traditionally used in the Jongilanga community in Mpumalanga , 2019, South African Journal of Botany.

[9]  Mingchun Liu,et al.  Flavanoids derivatives from the root bark of Broussonetia papyrifera as a tyrosinase inhibitor , 2019, Industrial Crops and Products.

[10]  A. Tackett,et al.  Current state of melanoma diagnosis and treatment , 2019, Cancer biology & therapy.

[11]  K. Park,et al.  Tyrosinase inhibitory study of flavonolignans from the seeds of Silybum marianum (Milk thistle). , 2019, Bioorganic & medicinal chemistry.

[12]  A. Ndhlala,et al.  The cosmetic potential of plants from the Eastern Cape Province traditionally used for skincare and beauty , 2019, South African Journal of Botany.

[13]  Yun-Ling Zheng,et al.  Anti-melanogenesis properties of condensed tannins from Vigna angularis seeds with potent antioxidant and DNA damage protection activities. , 2019, Food & function.

[14]  N. Lall,et al.  Selected South African plants with tyrosinase enzyme inhibition and their effect on gene expression , 2019, South African Journal of Botany.

[15]  Wei Song,et al.  Structure Elucidation and Evaluation of Antioxidant and Tyrosinase Inhibitory Effect and Mechanism of Proanthocyanidins from Leaf and Fruit of Leucaena Leucocephala , 2018, Journal of Wood Chemistry and Technology.

[16]  M. Morra,et al.  Sinapis alba seed meal as a feedstock for extracting the natural tyrosinase inhibitor 4-hydroxybenzyl alcohol , 2018, Industrial Crops and Products.

[17]  Yan-ying Yu,et al.  The antityrosinase and antioxidant activities of flavonoids dominated by the number and location of phenolic hydroxyl groups , 2018, Chinese Medicine.

[18]  C. Shang,et al.  Integrated study of the mechanism of tyrosinase inhibition by baicalein using kinetic, multispectroscopic and computational simulation analyses. , 2018, International journal of biological macromolecules.

[19]  H. Chung,et al.  A Potent Tyrosinase Inhibitor, (E)-3-(2,4-Dihydroxyphenyl)-1-(thiophen-2-yl)prop-2-en-1-one, with Anti-Melanogenesis Properties in α-MSH and IBMX-Induced B16F10 Melanoma Cells , 2018, Molecules.

[20]  Wen-Yang Huang,et al.  Antityrosinase and antioxidant properties of mung bean seed proanthocyanidins: Novel insights into the inhibitory mechanism. , 2018, Food chemistry.

[21]  V. Hearing,et al.  Inhibition of Human Tyrosinase Requires Molecular Motifs Distinctively Different from Mushroom Tyrosinase. , 2018, The Journal of investigative dermatology.

[22]  K. Umehara,et al.  Correlation between the Potency of Flavonoids on Mushroom Tyrosinase Inhibitory Activity and Melanin Synthesis in Melanocytes , 2018, Molecules.

[23]  C. Shang,et al.  The effect of 7,8,4´-trihydroxyflavone on tyrosinase activity and conformation: Spectroscopy and docking studies. , 2018, Luminescence : the journal of biological and chemical luminescence.

[24]  Wei Song,et al.  Isolation and Purification of Condensed Tannin from the Leaves and Branches of Prunus cerasifera and Its Structure and Bioactivities , 2018, Applied Biochemistry and Biotechnology.

[25]  V. Namasivayam,et al.  Inhibitors of Melanogenesis: An Updated Review. , 2018, Journal of medicinal chemistry.

[26]  A. Hou,et al.  Isoprenylated phenolic compounds with tyrosinase inhibition from Morus nigra , 2018, Journal of Asian natural products research.

[27]  J. Szaflarski,et al.  How UV Light Touches the Brain and Endocrine System Through Skin, and Why , 2018, Endocrinology.

[28]  S. Lim,et al.  Antioxidant activity and inhibitory effects of 2-hydroxy-3-methylcyclopent-2-enone isolated from ribose-histidine Maillard reaction products on aldose reductase and tyrosinase. , 2018, Food & function.

[29]  H. Otsuka,et al.  Phenolic compounds from the leaves of Breynia officinalis and their tyrosinase and melanogenesis inhibitory activities , 2018, Journal of Natural Medicines.

[30]  Demetrios A. Spandidos,et al.  Cutaneous melanoma: From pathogenesis to therapy (Review) , 2018, International journal of oncology.

[31]  R. Heryanto,et al.  Melanogenesis inhibitory activity of components from Salam leaf (Syzygium polyanthum) extract , 2018, Journal of Natural Medicines.

[32]  N. Lall,et al.  Isolation of Flavonoids and Flavonoid Glycosides from Myrsine africana and Their Inhibitory Activities against Mushroom Tyrosinase. , 2018, Journal of natural products.

[33]  Y. H. Kim,et al.  Chemical Constituents from Apios americana and Their Inhibitory Activity on Tyrosinase , 2018, Molecules.

[34]  Peiming Yang,et al.  Isoprenylated Phenolic Compounds from Morus macroura as Potent Tyrosinase Inhibitors , 2017, Planta Medica.

[35]  Wen-Yang Huang,et al.  Inhibition of tyrosinase by cherimoya pericarp proanthocyanidins: Structural characterization, inhibitory activity and mechanism. , 2017, Food research international.

[36]  L. Pasquier,et al.  Flavonol glycosides and lignans from the leaves of Opilia amentacea , 2017 .

[37]  G. Sethi,et al.  Phytometabolites Targeting the Warburg Effect in Cancer Cells: A Mechanistic Review. , 2017, Current drug targets.

[38]  R. Ksouri,et al.  Anti-aging activities of extracts from Tunisian medicinal halophytes and their aromatic constituents , 2017, EXCLI journal.

[39]  I. Trougakos,et al.  Anti-Melanogenic Properties of Greek Plants. A Novel Depigmenting Agent from Morus alba Wood , 2017, Molecules.

[40]  Wei-Ming Chai,et al.  Proanthocyanidins purified from fruit pericarp of Clausena lansium (Lour.) Skeels as efficient tyrosinase inhibitors: structure evaluation, inhibitory activity and molecular mechanism. , 2017, Food & function.

[41]  I. Batubara,et al.  Anti-tyrosinase, total phenolic content and antioxidant activity of selected Sudanese medicinal plants , 2017 .

[42]  V. Namasivayam,et al.  Skin whitening agents: medicinal chemistry perspective of tyrosinase inhibitors , 2017, Journal of enzyme inhibition and medicinal chemistry.

[43]  P. Bałczewski,et al.  New Hopes in Cancer Battle - A Review of New Molecules and Treatment Strategies. , 2016, Medicinal chemistry (Shariqah (United Arab Emirates)).

[44]  N. Lall,et al.  Insights into tyrosinase inhibition by compounds isolated from Greyia radlkoferi Szyszyl using biological activity, molecular docking and gene expression analysis. , 2016, Bioorganic & medicinal chemistry.

[45]  Jianmin Chen,et al.  Inhibitory mechanisms of glabridin on tyrosinase. , 2016, Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy.

[46]  L. Bubacco,et al.  Are Human Tyrosinase and Related Proteins Suitable Targets for Melanoma Therapy? , 2016, Current topics in medicinal chemistry.

[47]  A. Bishayee,et al.  Cancer prevention and therapy through the modulation of transcription factors by bioactive natural compounds. , 2016, Seminars in cancer biology.

[48]  Zong-Ping Zheng,et al.  Characterization of a New Flavone and Tyrosinase Inhibition Constituents from the Twigs of Morus alba L. , 2016, Molecules.

[49]  Yan Shi,et al.  Condensed tannins from Ficus altissima leaves: Structural, antioxidant, and antityrosinase properties , 2016 .

[50]  Abubaker M. A. Morgan,et al.  Chemical Components from the Stems of Pueraria lobata and Their Tyrosinase Inhibitory Activity , 2016 .

[51]  B. Bastian,et al.  From melanocytes to melanomas , 2016, Nature Reviews Cancer.

[52]  H. Tsao,et al.  Hereditary melanoma: Update on syndromes and management: Genetics of familial atypical multiple mole melanoma syndrome. , 2016, Journal of the American Academy of Dermatology.

[53]  A. Brożyna,et al.  Melanin content in melanoma metastases affects the outcome of radiotherapy , 2016, Oncotarget.

[54]  N. Nguyen,et al.  Tyrosinase inhibitory activity of flavonoids from Artocarpus heterophyllous , 2016, Chemistry Central Journal.

[55]  Keun Woo Lee,et al.  Highly potent tyrosinase inhibitor, neorauflavane from Campylotropis hirtella and inhibitory mechanism with molecular docking. , 2016, Bioorganic & medicinal chemistry.

[56]  Mankun Wei,et al.  Proanthocyanidins Extracted from Rhododendron pulchrum Leaves as Source of Tyrosinase Inhibitors: Structure, Activity, and Mechanism , 2015, PloS one.

[57]  N. Hayward,et al.  Melanoma genetics , 2015, Journal of Medical Genetics.

[58]  Mankun Wei,et al.  Avocado Proanthocyanidins as a Source of Tyrosinase Inhibitors: Structure Characterization, Inhibitory Activity, and Mechanism. , 2015, Journal of agricultural and food chemistry.

[59]  Thanigaimalai Pillaiyar,et al.  Inhibitors of melanogenesis: a patent review (2009 – 2014) , 2015, Expert opinion on therapeutic patents.

[60]  Nicolas C. Nicolaides,et al.  Chrousos syndrome: from molecular pathogenesis to therapeutic management , 2015, European journal of clinical investigation.

[61]  A. Brożyna,et al.  The role of melanogenesis in regulation of melanoma behavior: melanogenesis leads to stimulation of HIF-1α expression and HIF-dependent attendant pathways. , 2014, Archives of biochemistry and biophysics.

[62]  S. Tanuma,et al.  Structure-activity relationships of the thujaplicins for inhibition of human tyrosinase. , 2014, Bioorganic & medicinal chemistry.

[63]  Mahmud Tareq Hassan Khan,et al.  Tyrosinase enzyme: 1. An overview on a pharmacological target. , 2014, Current topics in medicinal chemistry.

[64]  C. A. Ramsden,et al.  Tyrosinase: the four oxidation states of the active site and their relevance to enzymatic activation, oxidation and inactivation. , 2014, Bioorganic & medicinal chemistry.

[65]  F. Solano.  Melanins: Skin Pigments and Much More—Types, Structural Models, Biological Functions, and Formation Routes , 2014 .

[66]  Wei-Ming Chai,et al.  Condensed Tannins from Ficus virens as Tyrosinase Inhibitors: Structure, Inhibitory Activity and Molecular Mechanism , 2014, PloS one.

[67]  A. Brożyna,et al.  Melanogenesis affects overall and disease-free survival in patients with stage III and IV melanoma. , 2013, Human pathology.

[68]  F. Della Ragione,et al.  Naturally occurring molecules and anticancer combination therapies in the era of personalized medicine and economic crisis. , 2013, Current pharmaceutical design.

[69]  D. Tobin,et al.  Key role of CRF in the skin stress response system. , 2013, Endocrine reviews.

[70]  G. Ghanem,et al.  Tyrosinase modulation by five Rwandese herbal medicines traditionally used for skin treatment. , 2013, Journal of ethnopharmacology.

[71]  L. Kolbe,et al.  4‐n‐butylresorcinol, a highly effective tyrosinase inhibitor for the topical treatment of hyperpigmentation , 2013, Journal of the European Academy of Dermatology and Venereology : JEADV.

[72]  Chi-Tang Ho,et al.  Tyrosinase inhibitory components of immature calamondin peel. , 2012, Food chemistry.

[73]  H. Kluger,et al.  Driver Mutations in Melanoma: Lessons Learned From Bench-to-Bedside Studies , 2012, Current Oncology Reports.

[74]  N. Lall,et al.  Melanogenesis and Antityrosinase Activity of Selected South African Plants , 2012, Evidence-based complementary and alternative medicine : eCAM.

[75]  G. Ren,et al.  Mushroom tyrosinase inhibitors from mung bean (Vigna radiatae L.) extracts , 2012, International journal of food sciences and nutrition.

[76]  V. Sondak,et al.  A brief history of melanoma: from mummies to mutations , 2012, Melanoma research.

[77]  A. Slominski,et al.  L‐tyrosine and L‐dihydroxyphenylalanine as hormone‐like regulators of melanocyte functions , 2012, Pigment cell & melanoma research.

[78]  R. Sayre,et al.  Cutaneous hypothalamic-pituitary-adrenal axis homolog: regulation by ultraviolet radiation. , 2011, American journal of physiology. Endocrinology and metabolism.

[79]  R. Scolyer,et al.  Evolving concepts in melanoma classification and their relevance to multidisciplinary melanoma patient care , 2011, Molecular oncology.

[80]  A. M. Khan,et al.  Tyrosinase inhibitory potential of natural products isolated from various medicinal plants , 2011, Natural product research.

[81]  Z. Wen,et al.  Identifying melanogenesis inhibitors from Cinnamomum subavenium with in vitro and in vivo screening systems by targeting the human tyrosinase , 2011, Experimental dermatology.

[82]  G. Fabbrocini,et al.  Epidemiology of Skin Cancer: Role of Some Environmental Factors , 2010, Cancers.

[83]  T. Slaga,et al.  Final Report of the Safety Assessment of Kojic Acid as Used in Cosmetics , 2010, International journal of toxicology.

[84]  D. Schadendorf,et al.  Improved survival with ipilimumab in patients with metastatic melanoma. , 2010, The New England journal of medicine.

[85]  D. Fisher,et al.  How Sunlight Causes Melanoma , 2010, Current oncology reports.

[86]  J. Y. Lee,et al.  Natural ortho-dihydroxyisoflavone derivatives from aged Korean fermented soybean paste as potent tyrosinase and melanin formation inhibitors. , 2010, Bioorganic & medicinal chemistry letters.

[87]  N. Lee,et al.  Tyrosinase inhibitory constituents from the stems of Maackia fauriei , 2010, Phytotherapy research : PTR.

[88]  A. Slominski.  Neuroendocrine activity of the melanocyte , 2009, Experimental dermatology.

[89]  N. A. Williams,et al.  Tyrosinase activated melanoma prodrugs. , 2009, Anti-cancer agents in medicinal chemistry.

[90]  S. Capaccioli,et al.  Natural compounds for cancer treatment and prevention. , 2009, Pharmacological research.

[91]  A. Slominski,et al.  Inhibitors of melanogenesis increase toxicity of cyclophosphamide and lymphocytes against melanoma cells , 2009, International journal of cancer.

[92]  Alistair N. Hume,et al.  Melanosomes at a glance , 2008, Journal of Cell Science.

[93]  N. Lall,et al.  Inhibitory activities of mushroom tyrosine and DOPA oxidation by plant extracts , 2008 .

[94]  H. Wojtasek,et al.  Indirect oxidation of the antitumor agent procarbazine by tyrosinase--possible application in designing anti-melanoma prodrugs. , 2008, Bioorganic & medicinal chemistry letters.

[95]  V. Hearing,et al.  The Protective Role of Melanin Against UV Damage in Human Skin † , 2008, Photochemistry and photobiology.

[96]  K. Schallreuter,et al.  Regulation of melanogenesis – controversies and new concepts , 2008, Experimental dermatology.

[97]  K. Park,et al.  Inhibitory effects on mushroom tyrosinase by flavones from the stem barks of Morus lhou (S.) Koidz , 2008 .

[98]  D. Tobin,et al.  Does p53 regulate skin pigmentation by controlling proopiomelanocortin gene transcription? , 2007, Pigment cell research.

[99]  M. Ichihashi,et al.  Approaches to identify inhibitors of melanin biosynthesis via the quality control of tyrosinase. , 2007, The Journal of investigative dermatology.

[100]  David E. Fisher,et al.  Central Role of p53 in the Suntan Response and Pathologic Hyperpigmentation , 2007, Cell.

[101]  G. Colditz,et al.  Melanocortin 1 receptor variants and skin cancer risk , 2006, International journal of cancer.

[102]  L. Thomas,et al.  Acral lentiginous melanoma: a clinicoprognostic study of 126 cases , 2006, The British journal of dermatology.

[103]  D. Tobin,et al.  Corticotropin releasing hormone and the skin. , 2006, Frontiers in bioscience : a journal and virtual library.

[104]  Kyoung-Chan Park,et al.  Sphingosylphosphorylcholine-induced ERK activation inhibits melanin synthesis in human melanocytes. , 2006, Pigment cell research.

[105]  A. Slominski,et al.  CRH functions as a growth factor/cytokine in the skin , 2006, Journal of cellular physiology.

[106]  Jeong Ah Kim,et al.  Inhibitory effect of piperlonguminine on melanin production in melanoma B16 cell line by downregulation of tyrosinase expression. , 2006, Pigment cell research.

[107]  S. Orlow,et al.  Degradation of tyrosinase induced by phenylthiourea occurs following Golgi maturation. , 2005, Pigment cell research.

[108]  M. Low,et al.  Preservation of eumelanin hair pigmentation in proopiomelanocortin-deficient mice on a nonagouti (a/a) genetic background. , 2005, Endocrinology.

[109]  H. Chung,et al.  4,4'-Dihydroxybiphenyl as a new potent tyrosinase inhibitor. , 2005, Biological & pharmaceutical bulletin.

[110]  Hang-Ching Lin,et al.  Identifying 6,7,4′-Trihydroxyisoflavone as a Potent Tyrosinase Inhibitor , 2005, Bioscience, biotechnology, and biochemistry.

[111]  Hyun Pyo Kim,et al.  Prenylated flavonoids as tyrosinase inhibitors , 2004, Archives of pharmacal research.

[112]  J. Rees,et al.  The genetics of sun sensitivity in humans. , 2004, American journal of human genetics.

[113]  I. Yoo,et al.  Terrein: a new melanogenesis inhibitor and its mechanism , 2004, Cellular and Molecular Life Sciences CMLS.

[114]  D. Tobin,et al.  Melanin pigmentation in mammalian skin and its hormonal regulation. , 2004, Physiological reviews.

[115]  B. Fuller,et al.  The relationship between Na(+)/H(+) exchanger expression and tyrosinase activity in human melanocytes. , 2004, Experimental cell research.

[116]  S. Orlow,et al.  25-hydroxycholesterol acts in the Golgi compartment to induce degradation of tyrosinase. , 2004, Pigment cell research.

[117]  M. Ichihashi,et al.  Down-regulation of Melanogenesis by Phospholipase D2 through Ubiquitin Proteasome-mediated Degradation of Tyrosinase* , 2004, Journal of Biological Chemistry.

[118]  Nico P E Vermeulen,et al.  Enzyme-Catalyzed Activation of Anticancer Prodrugs , 2004, Pharmacological Reviews.

[119]  Kyoung-Chan Park,et al.  (−)-Epigallocatechin-3-gallate and hinokitiol reduce melanin synthesisvia decreased MITF production , 2004, Archives of pharmacal research.

[120]  Kyoung-Chan Park,et al.  Effects of lysophosphatidic acid on melanogenesis. , 2004, Chemistry and physics of lipids.

[121]  J. Annereau,et al.  Regulation of melanocortin 1 receptor expression at the mRNA and protein levels by its natural agonist and antagonist , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[122]  K. Wakamatsu,et al.  Quantitative analysis of eumelanin and pheomelanin in humans, mice, and other animals: a comparative review. , 2003, Pigment cell research.

[123]  Kyoko Nakamura,et al.  Down-regulation of melanin synthesis by a biphenyl derivative and its mechanism. , 2003, Pigment cell research.

[124]  M. Pagel,et al.  A naked ape would have fewer parasites , 2003, Proceedings of the Royal Society of London. Series B: Biological Sciences.

[125]  C. A. Ramsden,et al.  Mechanistic studies of catechol generation from secondary quinone amines relevant to indole formation and tyrosinase activation. , 2003, Pigment cell research.

[126]  V. Hearing,et al.  Tyrosinase processing and intracellular trafficking is disrupted in mouse primary melanocytes carrying the underwhite (uw) mutation. A model for oculocutaneous albinism (OCA) type 4 , 2003, Journal of Cell Science.

[127]  Chung S. Yang,et al.  Inhibitory effect of red koji extracts on mushroom tyrosinase. , 2003, Journal of agricultural and food chemistry.

[128]  V. Hearing,et al.  The Seiji memorial lecture: the melanosome: an ideal model to study cellular differentiation. , 2003, Pigment cell research.

[129]  J. Borovanský,et al.  Melanosome degradation: fact or fiction. , 2003, Pigment cell research.

[130]  M. Tucker,et al.  Melanoma etiology: where are we? , 2003, Oncogene.

[131]  Kyoung-Chan Park,et al.  Sphingosine-1-phosphate decreases melanin synthesis via sustained ERK activation and subsequent MITF degradation , 2003, Journal of Cell Science.

[132]  C. A. Ramsden,et al.  Tyrosinase autoactivation and the chemistry of ortho-quinone amines. , 2003, Accounts of chemical research.

[133]  G. Wolff.  Regulation of yellow pigment formation in mice: a historical perspective. , 2003, Pigment cell research.

[134]  A. Bode,et al.  Mitogen-Activated Protein Kinase Activation in UV-Induced Signal Transduction , 2003, Science's STKE.

[135]  E. Price,et al.  Modulation of microphthalmia-associated transcription factor gene expression alters skin pigmentation. , 2002, The Journal of investigative dermatology.

[136]  M. Fukuda,et al.  Changes in the proliferative activity of epidermal melanocytes in serum-free primary culture during the development of ultraviolet radiation B-induced pigmented spots in hairless mice. , 2002, Pigment cell research.

[137]  R. Halaban,et al.  Coexpression of wild-type tyrosinase enhances maturation of temperature-sensitive tyrosinase mutants. , 2002, The Journal of investigative dermatology.

[138]  V. Ferrans,et al.  The etiology of oculocutaneous albinism (OCA) type II: the pink protein modulates the processing and transport of tyrosinase. , 2002, Pigment cell research.

[139]  S. Orlow,et al.  Pink-eyed dilution protein controls the processing of tyrosinase. , 2002, Molecular biology of the cell.

[140]  R. Halaban,et al.  Abnormal Acidification of Melanoma Cells Induces Tyrosinase Retention in the Early Secretory Pathway* , 2002, The Journal of Biological Chemistry.

[141]  D. I. Våge,et al.  The regulatory basis of melanogenic switching. , 2002, Journal of theoretical biology.

[142]  M. Hochstrasser,et al.  A conserved ubiquitin ligase of the nuclear envelope/endoplasmic reticulum that functions in both ER-associated and Matalpha2 repressor degradation. , 2001, Genes & development.

[143]  V. Ferrans,et al.  Oculocutaneous albinism types 1 and 3 are ER retention diseases: mutation of tyrosinase or Tyrp1 can affect the processing of both mutant and wild‐type proteins , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[144]  J. Mazurkiewicz,et al.  Cutaneous expression of corticotropin‐releasing hormone (CRH), urocortin, and CRH receptors , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[145]  R. Spritz,et al.  The molecular basis of oculocutaneous albinism type 1 (OCA1): sorting failure and degradation of mutant tyrosinases results in a lack of pigmentation. , 2001, The Biochemical journal.

[146]  V. A. Filov,et al.  Inhibition of mouse melanoma cell proliferation by corticotropin-releasing hormone and its analogs. , 2001, Anticancer research.

[147]  G. Raposo,et al.  Distinct Protein Sorting and Localization to Premelanosomes, Melanosomes, and Lysosomes in Pigmented Melanocytic Cells✪ , 2001, The Journal of cell biology.

[148]  B. Fuller,et al.  Regulation of the catalytic activity of preexisting tyrosinase in black and Caucasian human melanocyte cell cultures. , 2001, Experimental cell research.

[149]  J. Mercer,et al.  The Menkes copper transporter is required for the activation of tyrosinase. , 2000, Human molecular genetics.

[150]  J. Park,et al.  Assembly, target-signaling and intracellular transport of tyrosinase gene family proteins in the initial stage of melanosome biogenesis. , 2000, Pigment cell research.

[151]  R. Paus,et al.  Corticotropin releasing hormone and proopiomelanocortin involvement in the cutaneous response to stress. , 2000, Physiological reviews.

[152]  V. Setaluri.  Sorting and targeting of melanosomal membrane proteins: signals, pathways, and mechanisms. , 2000, Pigment cell research.

[153]  T. Yamashita,et al.  Intracellular vesicular trafficking of tyrosinase gene family protein in eu- and pheomelanosome biogenesis. , 2000, Pigment cell research.

[154]  G. Barsh,et al.  Biochemical and genetic studies of pigment-type switching. , 2000, Pigment cell research.

[155]  R. Halaban,et al.  Endoplasmic reticulum retention is a common defect associated with tyrosinase-negative albinism. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[156]  R. Buscà,et al.  Cyclic AMP a key messenger in the regulation of skin pigmentation. , 2000, Pigment cell research.

[157]  P. Riley.  Tyrosinase kinetics: a semi-quantitative model of the mechanism of oxidation of monohydric and dihydric phenolic substrates. , 2000, Journal of theoretical biology.

[158]  R. Halaban.  The regulation of normal melanocyte proliferation. , 2000, Pigment cell research.

[159]  B. Gilchrest,et al.  Signaling pathways mediating melanogenesis. , 1999, Cellular and molecular biology.

[160]  R. Paus,et al.  Cutaneous Expression of CRH and CRH‐R: Is There a “Skin Stress Response System?” , 1999, Annals of the New York Academy of Sciences.

[161]  R. Paus,et al.  The Skin POMC System (SPS): Leads and Lessons from the Hair Follicle , 1999, Annals of the New York Academy of Sciences.

[162]  T. Luger,et al.  Role of Epidermal Cell‐Derived α‐Melanocyte Stimulating Hormone in Ultraviolet Light Mediated Local Immunosuppression , 1999, Annals of the New York Academy of Sciences.

[163]  L. Yaswen,et al.  Obesity in the mouse model of pro-opiomelanocortin deficiency responds to peripheral melanocortin , 1999, Nature Medicine.

[164]  B. Gilchrest,et al.  DNA photodamage stimulates melanogenesis and other photoprotective responses. , 1999, The journal of investigative dermatology. Symposium proceedings.

[165]  V. Hearing.  Biochemical control of melanogenesis and melanosomal organization. , 1999, The journal of investigative dermatology. Symposium proceedings.

[166]  M. Ichihashi,et al.  Possible involvement of proteolytic degradation of tyrosinase in the regulatory effect of fatty acids on melanogenesis. , 1999, Journal of lipid research.

[167]  B. Gilchrest,et al.  The pathogenesis of melanoma induced by ultraviolet radiation. , 1999, The New England journal of medicine.

[168]  Y. Hsin-Su.  The Pigmentary System: Physiology and Pathophysiology , 1999 .

[169]  J. Mazurkiewicz,et al.  Expression of proopiomelanocortin (POMC)-derived melanocyte-stimulating hormone (MSH) and adrenocorticotropic hormone (ACTH) peptides in skin of basal cell carcinoma patients. , 1999, Human pathology.

[170]  J. Hebebrand,et al.  Systematic mutation screening of the pro-opiomelanocortin gene: identification of several genetic variants including three different insertions, one nonsense and two missense point mutations in probands of different weight extremes. , 1998, The Journal of clinical endocrinology and metabolism.

[171]  M. Choudhry,et al.  Effect of CRF and related peptides on calcium signaling in human and rodent melanoma cells , 1998, FEBS letters.

[172]  M. Mihm,et al.  Inhibition of melanogenesis as an adjuvant strategy in the treatment of melanotic melanomas: selective review and hypothesis. , 1998, Anticancer research.

[173]  A. Slominski.  Identification of β‐endorphin, α‐MSH and ACTH peptides in cultured human melanocytes, melanoma and squamous cell carcinoma cells by RP‐HPLC , 1998 .

[174]  I. Jackson,et al.  Melanocortin receptors and antagonists regulate pigmentation and body weight. , 1998, BioEssays : news and reviews in molecular, cellular and developmental biology.

[175]  A. Slominski,et al.  Animals under the sun: effects of ultraviolet radiation on mammalian skin. , 1998, Clinics in dermatology.

[176]  Ohashi,et al.  Immunoreactivity of α‐melanocyte‐stimulating hormone, adrenocorticotrophic hormone and β‐endorphin in cutaneous malignant melanoma and benign melanocytic naevi , 1998, The British journal of dermatology.

[177]  A. Grüters,et al.  Severe early-onset obesity, adrenal insufficiency and red hair pigmentation caused by POMC mutations in humans , 1998, Nature Genetics.

[178]  R. Paus,et al.  Cutaneous Immunomodulation and Coordination of Skin Stress Responses by α‐Melanocyte‐Stimulating Hormone a , 1998 .

[179]  B. Mintz,et al.  Qualitative and quantitative catalog of tyrosinase alternative transcripts in normal murine skin melanocytes as a basis for detecting melanoma-specific changes. , 1997, Biochemical and biophysical research communications.

[180]  R. Dwek,et al.  Inhibition of N-Glycan Processing in B16 Melanoma Cells Results in Inactivation of Tyrosinase but Does Not Prevent Its Transport to the Melanosome* , 1997, The Journal of Biological Chemistry.

[181]  R. Halaban,et al.  Aberrant retention of tyrosinase in the endoplasmic reticulum mediates accelerated degradation of the enzyme and contributes to the dedifferentiated phenotype of amelanotic melanoma cells. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[182]  W. Silvers,et al.  Selective increase in specific alternative splice variants of tyrosinase in murine melanomas: a projected basis for immunotherapy. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[183]  J. Ortonne,et al.  Nitric oxide produced by ultraviolet-irradiated keratinocytes stimulates melanogenesis. , 1997, The Journal of clinical investigation.

[184]  G. Ermak,et al.  Production of POMC, CRH-R1, MC1, and MC2 receptor mRNA and expression of tyrosinase gene in relation to hair cycle and dexamethasone treatment in the C57BL/6 mouse skin. , 1997, The Journal of investigative dermatology.

[185]  M. Mihm,et al.  POTENTIAL MECHANISM OF SKIN RESPONSE TO STRESS , 1996, International journal of dermatology.

[186]  K. Wakamatsu,et al.  Cysteine deprivation promotes eumelanogenesis in human melanoma cells. , 1996, The Journal of investigative dermatology.

[187]  S. Aaronson,et al.  Alkaptonuria: such a long journey , 1996, Nature Genetics.

[188]  A. Chakraborty,et al.  Production and release of proopiomelanocortin (POMC) derived peptides by human melanocytes and keratinocytes in culture: regulation by ultraviolet B. , 1996, Biochimica et biophysica acta.

[189]  G. Barsh,et al.  The genetics of pigmentation: from fancy genes to complex traits. , 1996, Trends in genetics : TIG.

[190]  J. Mazurkiewicz,et al.  The expression of proopiomelanocortin (POMC) and of corticotropin releasing hormone receptor (CRH-R) genes in mouse skin. , 1996, Biochimica et biophysica acta.

[191]  V. del Marmol,et al.  Tyrosinase and related proteins in mammalian pigmentation , 1996, FEBS letters.

[192]  A. Chakraborty,et al.  Ultraviolet B and melanocyte-stimulating hormone (MSH) stimulate mRNA production for alpha MSH receptors and proopiomelanocortin-derived peptides in mouse melanoma cells and transformed keratinocytes. , 1995, The Journal of investigative dermatology.

[193]  M. Mihm,et al.  Proopiomelanocortin, corticotropin releasing hormone and corticotropin releasing hormone receptor genes are expressed in human skin , 1995, FEBS letters.

[194]  E. Medrano,et al.  Thy‐1 + dendritic cells express truncated form of POMC mRNA , 1995, Experimental dermatology.

[195]  L. Sandkuijl,et al.  Homozygotes for CDKN2 (p16) germline mutation in Dutch familial melanoma kindreds , 1995, Nature Genetics.

[196]  A. Eberle,et al.  Melanocortins and their implication in melanoma , 1995, Trends in Endocrinology & Metabolism.

[197]  J N Rodríguez-López,et al.  Tyrosinase: a comprehensive review of its mechanism. , 1995, Biochimica et biophysica acta.

[198]  M. L. Gardner,et al.  A specific tetrahydrobiopterin binding domain on tyrosinase controls melanogenesis. , 1995, Biochemical and biophysical research communications.

[199]  M. Skolnick,et al.  Penetrance and expressivity of the chromosome 9p melanoma susceptibility locus (MLM). , 1994, Cancer research.

[200]  S. Orlow,et al.  High-molecular-weight forms of tyrosinase and the tyrosinase-related proteins: evidence for a melanogenic complex. , 1994, The Journal of investigative dermatology.

[201]  S. Eichmüller,et al.  A murine model for inducing and manipulating hair follicle regression (catagen): effects of dexamethasone and cyclosporin A. , 1994, The Journal of investigative dermatology.

[202]  F. Trautinger,et al.  Proopiomelanocortin-derived peptides are synthesized and released by human keratinocytes. , 1994, The Journal of clinical investigation.

[203]  M. Pittelkow,et al.  Regulation of melanin biosynthesis in the human epidermis by tetrahydrobiopterin. , 1994, Science.

[204]  R. Paus,et al.  Towards defining receptors for l-tyrosine and l-DOPA , 1994, Molecular and Cellular Endocrinology.

[205]  S. Anjaiah,et al.  pH of melanosomes of B 16 murine melanoma is acidic: its physiological importance in the regulation of melanin biosynthesis. , 1993, Archives of biochemistry and biophysics.

[206]  B. Armstrong,et al.  How much melanoma is caused by sun exposure? , 1993, Melanoma research.

[207]  D. Schadendorf,et al.  Melanocytes as "sensory" and regulatory cells in the epidermis. , 1993, Journal of theoretical biology.

[208]  M. A. Everett,et al.  Role of tyrosinase as the determinant of pigmentation in cultured human melanocytes. , 1993, The Journal of investigative dermatology.

[209]  R. Paus,et al.  On the potential role of proopiomelanocortin in skin physiology and pathology , 1993, Molecular and Cellular Endocrinology.

[210]  Z. Abdel‐Malek,et al.  The Expression of Proopiomelanocortin and Various POMC‐Derived Peptides in Mouse and Human Skin , 1993, Annals of the New York Academy of Sciences.

[211]  A. Lerner.  The Discovery of the Melanotropins: A History of Pituitary Endocrinology a , 1993, Annals of the New York Academy of Sciences.

[212]  B. Kwon,et al.  Pigmentation genes: the tyrosinase gene family and the pmel 17 gene family. , 1993, The Journal of investigative dermatology.

[213]  K. Rosenzweig,et al.  Molecular cascades in UV-induced melanogenesis: a central role for melanotropins? , 1992, Pigment cell research.

[214]  K. Kraning,et al.  Human thermoregulatory responses during heat exposure after artificially induced sunburn. , 1992, The American journal of physiology.

[215]  R. Jung,et al.  A case of skin hyperpigmentation due to α‐MSH hypersecretion , 1992 .

[216]  L. Tabe,et al.  Inhibition of melanogenesis by BMY-28565, a novel compound depressing tyrosinase activity in B16 melanoma cells. , 1992, Biochemical pharmacology.

[217]  J. Mazurkiewicz,et al.  Proopiomelanocortin expression in the skin during induced hair growth in mice , 1992, Experientia.

[218]  J. Mazurkiewicz,et al.  Pro‐opiomelanocortin Expression and Potential Function of Pro‐opiomelanocortin Products during Induced Hair Growth in Mice a , 1991, Annals of the New York Academy of Sciences.

[219]  V. Hearing,et al.  Enzymatic control of pigmentation in mammals , 1991, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[220]  A. Slominski,et al.  POMC gene expression in mouse and hamster melanoma cells , 1991, FEBS letters.

[221]  A. Slominski,et al.  L-tyrosine induces tyrosinase expression via a posttranscriptional mechanism , 1991, Experientia.

[222]  Robert M. Sayre,et al.  New trends in photobiology: Photoprotection by melanin , 1991 .

[223]  R. Spritz,et al.  Organization and nucleotide sequences of the human tyrosinase gene and a truncated tyrosinase-related segment. , 1991, Genomics.

[224]  U. Francke,et al.  Homozygous tyrosinase gene mutation in an American black with tyrosinase-negative (type IA) oculocutaneous albinism. , 1991, American journal of human genetics.

[225]  R. Paus,et al.  Differential expression and activity of melanogenesis-related proteins during induced hair growth in mice. , 1991, The Journal of investigative dermatology.

[226]  B. Mintz,et al.  Multiple alternatively spliced transcripts of the mouse tyrosinase-encoding gene. , 1991, Gene.

[227]  S. Shibahara,et al.  Molecular basis of tyrosinase-negative oculocutaneous albinism. A single base mutation in the tyrosinase gene causing arginine to glutamine substitution at position 59. , 1990, The Journal of biological chemistry.

[228]  G. Hoganson,et al.  Down-regulation of tyrosinase mRNA levels in melanoma cells by tumor promoters and by insulin , 1990, Molecular and Cellular Endocrinology.

[229]  M. A. Everett,et al.  The relationship between tyrosinase activity and skin color in human foreskins. , 1990, The Journal of investigative dermatology.

[230]  J. D. de Haan,et al.  Effect of thymidine analogs on tyrosinase activity and mRNA accumulation in mouse melanoma cells. , 1990, Experimental cell research.

[231]  R. Paus,et al.  Are L-tyrosine and L-dopa hormone-like bioregulators? , 1990, Journal of theoretical biology.

[232]  A. Takeda,et al.  Human oculocutaneous albinism caused by single base insertion in the tyrosinase gene. , 1989, Biochemical and biophysical research communications.

[233]  V. Hearing,et al.  Regulation of mammalian melanogenesis by tyrosinase inhibition. , 1989, Differentiation; research in biological diversity.

[234]  G. Imokawa.  Analysis of initial melanogenesis including tyrosinase transfer and melanosome differentiation through interrupted melanization by glutathione. , 1989, The Journal of investigative dermatology.

[235]  A. Slominski,et al.  MSH inhibits growth in a line of amelanotic hamster melanoma cells and induces increases in cyclic AMP levels and tyrosinase activity without inducing melanogenesis. , 1989, Journal of cell science.

[236]  A. Slominski,et al.  L-tyrosine, L-dopa, and tyrosinase as positive regulators of the subcellular apparatus of melanogenesis in Bomirski Ab amelanotic melanoma cells. , 1989, Pigment cell research.

[237]  S. Shibahara,et al.  Molecular basis for the heterogeneity of human tyrosinase. , 1988, The Tohoku journal of experimental medicine.

[238]  A. Slominski,et al.  Regulation of Melanogenesis in Melanocytes , 1988 .

[239]  G. Schütz,et al.  Functional analysis of alternatively spliced tyrosinase gene transcripts. , 1988, The EMBO journal.

[240]  G. Schütz,et al.  Multiple transcripts of the mouse tyrosinase gene are generated by alternative splicing. , 1988, The EMBO journal.

[241]  D. Barton,et al.  Human tyrosinase gene, mapped to chromosome 11 (q14----q21), defines second region of homology with mouse chromosome 7. , 1988, Genomics.

[242]  A. Slominski,et al.  The natural history of a family of transplantable melanomas in hamsters , 1988, Cancer and Metastasis Reviews.

[243]  P. Haninec,et al.  Tyrosinase protein is expressed also in some neural crest derived cells which are not melanocytes. , 1988, Pigment cell research.

[244]  B. Kwon,et al.  Isolation and sequence of a cDNA clone for human tyrosinase that maps at the mouse c-albino locus. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[245]  S. Shuster,et al.  MSH peptides are present in mammalian skin , 1983, Peptides.

[246]  J. Pawelek,et al.  Mammalian tyrosinase catalyzes three reactions in the biosynthesis of melanin. , 1982, Science.

[247]  G. Imokawa,et al.  Loss of melanogenic properties in tyrosinases induced by glucosylation inhibitors within malignant melanoma cells. , 1982, Cancer research.

[248]  A. Oikawa,et al.  Synthesis and degradation of tyrosinase in cultured melanoma cells , 1980, Journal of cellular physiology.

[249]  J. Eaton,et al.  Skin color and nutrient photolysis: an evolutionary hypothesis. , 1978, Science.

[250]  J. Pawelek,et al.  Activation of melanoma tyrosinase by a cyclic AMP-dependent protein kinase in a cell-free system , 1977, Nature.

[251]  J. Pawelek,et al.  Melanocyte-stimulating hormone promotes activation of pre-existing tyrosinase molecules in Cloudman S91 melanoma cells , 1975, Nature.

[252]  R. Binford,et al.  Cold injury and the evolution of "white" skin. , 1975, Human biology.

[253]  H. Machida,et al.  The skin of primates. XXXII. The Philippine tarsier (Tarsius syrichta). , 1966, American journal of physical anthropology.

[254]  A. Lerner,et al.  Effect of Alpha- and Beta-Melanocyte Stimulating Hormones on the Skin Colour of Man , 1961, Nature.

[255]  H. Raper.  THE AEROBIC OXIDASES , 1928 .

[256]  F. Ghorat,et al.  GLOBAL INCIDENCE AND MORTALITY OF SKIN CANCER BY HISTOLOGICAL SUBTYPE AND ITS RELATIONSHIP WITH THE HUMAN DEVELOPMENT INDEX (HDI); , 2019 .

[257]  H. Chung,et al.  Evaluation of Antimelanogenic Activity and Mechanism of Galangin in Silico and in Vivo. , 2018, Biological & pharmaceutical bulletin.

[258]  E. Garo,et al.  Tyrosinase inhibitory constituents from a polyphenol enriched fraction of rose oil distillation wastewater. , 2016, Fitoterapia.

[259]  D. Hebert,et al.  Tyrosinase Maturation through the Mammalian Secretory Pathway: Bringing Color to Life , 2022 .

[260]  A. Chompret,et al.  Genetic and environmental factors in cutaneous malignant melanoma. , 2002, Biochimie.

[261]  R. Halaban.  Pigmentation in melanomas: changes manifesting underlying oncogenic and metabolic activities. , 2002, Oncology research.

[262]  W. Oetting,et al.  Molecular basis of albinism: Mutations and polymorphisms of pigmentation genes associated with albinism , 1999, Human mutation.

[263]  R. Plemper,et al.  Der3p/Hrd1p is required for endoplasmic reticulum-associated degradation of misfolded lumenal and integral membrane proteins. , 1998, Molecular biology of the cell.

[264]  F Beermann,et al.  New evidence for presence of tyrosinase in substantia nigra, forebrain and midbrain. , 1998, Brain research. Molecular brain research.

[265]  N. Hayward,et al.  Germline mutations in the p16INK4a binding domain of CDK4 in familial melanoma , 1996, Nature Genetics.

[266]  B. Gilchrest,et al.  Proopiomelanocortin, its derived peptides, and the skin. , 1996, The Journal of investigative dermatology.

[267]  A. Helenius,et al.  Quality control in the secretory pathway. , 1995, Current opinion in cell biology.

[268]  J. Bereiter-Hahn,et al.  α-MSH is expressed in cultured human melanocytes and keratinocytes , 1995 .

[269]  A. Thody.  Epidermal melanocytes : their regulation and role in skin pigmentation , 1995 .

[270]  J. Pawelek.  Proopiomelanocortin in skin: new possibilities for regulation of skin physiology. , 1993, The Journal of laboratory and clinical medicine.

[271]  A. Slominski,et al.  Molecular mechanisms governing melanogenesis in hamster melanomas: relative abundance of tyrosinase and catalase-B (gp 75). , 1991, Anticancer research.

[272]  N. Lindquist.  Accumulation of drugs on melanin. , 1973, Acta radiologica: diagnosis.

[273]  T. Fitzpatrick,et al.  Biochemistry of melanin formation. , 1950, Physiological reviews.